alnylam
The Associate Director, Observational Data Methods and Analytics at Alnylam specializes in real-world data analysis to support epidemiologic studies within the pharmaceutical industry. The role involves developing analytical data resources, conducting advanced observational analyses, and collaborating with internal teams and stakeholders to advance epidemiologic methods and analytical capabilities.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2002
Alnylam is a biopharmaceutical company that has pioneered RNA interference (RNAi) therapeutics, an innovative class of medicines that treats diseases by silencing the genes that cause or contribute to them. The company develops RNAi-based medicines targeting both rare and prevalent diseases across multiple therapeutic areas, with approved products and a robust investigational pipeline. Driven by science and inspired by patients, Alnylam is committed to delivering transformational medicines that address diseases at their genetic source.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for alnylam.
44% above the average for this role
Real World Data Statistician I/II
AstraZeneca
Director of Epidemiology & Methodological Innovation
Tempus AI
Statistical Programmer
Cytel
Senior Real World Data Statistician
AstraZeneca
Senior Real World Data Scientist Epidemiologist Biostatistician Kaiseraugst Switzerland
dsm
Senior Epidemiological Programmer, Real World Evidence - FSP
IQVIA